Headlines about K2M Group Holdings (NASDAQ:KTWO) have been trending somewhat positive recently, Accern reports. Accern ranks the sentiment of media coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. K2M Group Holdings earned a news sentiment score of 0.20 on Accern’s scale. Accern also gave press coverage about the medical device company an impact score of 45.748996395943 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near term.
Here are some of the media headlines that may have effected Accern’s rankings:
- K2M Group Holdings, Inc. (KTWO) PT Set at $28.00 by Cowen and Company (americanbankingnews.com)
- K2M Group Holdings, Inc. – Value Analysis (NASDAQ:KTWO) : August 17, 2017 (finance.yahoo.com)
- K2M Group Holdings Inc (KTWO) Insider John Philip Md Kostuik Sells 1,090 Shares (americanbankingnews.com)
- Gregory S. Cole Sells 2,350 Shares of K2M Group Holdings Inc (KTWO) Stock (americanbankingnews.com)
- K2M Group Holdings, Inc. (NASDAQ:KTWO) Trading Down – Insiders and Institutional Investors Selling, Short Interest Growing (highlightpress.com)
A number of research firms have recently commented on KTWO. Royal Bank Of Canada reiterated a “buy” rating on shares of K2M Group Holdings in a research report on Wednesday, May 3rd. Zacks Investment Research upgraded shares of K2M Group Holdings from a “sell” rating to a “hold” rating in a research report on Saturday, August 5th. Cowen and Company restated a “buy” rating and set a $26.00 price objective on shares of K2M Group Holdings in a report on Wednesday, July 19th. Barclays PLC upped their price objective on shares of K2M Group Holdings from $26.00 to $27.00 and gave the stock an “overweight” rating in a report on Monday, April 24th. Finally, Oppenheimer Holdings, Inc. set a $26.00 price objective on shares of K2M Group Holdings and gave the stock a “buy” rating in a report on Wednesday, May 3rd. Two equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus target price of $26.50.
Shares of K2M Group Holdings (NASDAQ:KTWO) traded down 1.30% during trading on Friday, reaching $23.45. 180,435 shares of the company’s stock were exchanged. The firm’s market cap is $1.01 billion. K2M Group Holdings has a 12 month low of $15.45 and a 12 month high of $25.99. The stock has a 50-day moving average price of $24.00 and a 200 day moving average price of $22.03.
K2M Group Holdings (NASDAQ:KTWO) last posted its quarterly earnings data on Tuesday, August 1st. The medical device company reported ($0.21) earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.22) by $0.01. The firm had revenue of $65.70 million for the quarter, compared to the consensus estimate of $66.26 million. K2M Group Holdings had a negative return on equity of 15.45% and a negative net margin of 16.21%. The company’s quarterly revenue was up 11.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned ($0.27) EPS. On average, analysts forecast that K2M Group Holdings will post ($0.78) EPS for the current year.
In related news, CFO Gregory S. Cole sold 2,350 shares of the company’s stock in a transaction dated Tuesday, August 15th. The stock was sold at an average price of $24.08, for a total value of $56,588.00. Following the completion of the sale, the chief financial officer now directly owns 55,158 shares of the company’s stock, valued at approximately $1,328,204.64. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CFO Gregory S. Cole sold 42,947 shares of the company’s stock in a transaction dated Friday, June 16th. The shares were sold at an average price of $22.80, for a total value of $979,191.60. Following the completion of the sale, the chief financial officer now directly owns 87,425 shares of the company’s stock, valued at $1,993,290. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 136,700 shares of company stock worth $3,140,059. 5.80% of the stock is owned by company insiders.
K2M Group Holdings Company Profile
K2M Group Holdings, Inc is a medical device company focused on designing, developing and commercializing spine and minimally invasive technologies and techniques. The Company’s solutions are focused on achieving three-dimensional Total Body Balance. Its spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor.
Receive News & Ratings for K2M Group Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.